Johnson & Johnson has launched its "Dual control" campaign in Asia Pacific, aiming to empower patients with inflammatory bowel disease (IBD) to manage their condition while pursuing life goals. The three-minute clip opens with three individuals reflecting on dreams they have put on hold due to other commitments and life choices. Singaporean patients will share personal stories through media channels, while a patient empowerment video, "#MyDualControl: Don’t let IBD put your dreams on hold", highlights real HCP-patient dialogues. By promoting shared decision-making, Johnson & Johnson hopes to help patients take dual control of both their health and their aspirations, improving treatment outcomes across the region. Targeting non-small cell lung cancer (NSCLC), the campaign encourages patients to consider their own perspective alongside their physician’s recommendation and a second opinion.